Nausea was reported in 57% of patients receiving semaglutide and 7% receiving placebo
Originally developed for managing type 2 diabetes, Semaglutide GLP-1 has also gained approval for weight management in certain individuals, making it a versatile tool in the pursuit of overall well-being
Monitor for right upper quadrant pain, especially in patients losing weight rapidly
Whether this applies to humans is not established, but both carry a FDA boxed warning and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2)
Semaglutide: Nausea, diarrhea, and constipation happen here, too, but people may handle it better if they start at a lower dose
Semaglutide reduces glucagon secretion from the alpha cells of the pancreas